← Back to guidelines
Cardiology27 papers

Late latent syphilis

Last edited: 4/22/2026

Overview

Late latent syphilis refers to a stage of syphilis that occurs 2 to 10 years after initial infection, characterized by absence of clinical symptoms and positive serological tests for syphilis without evidence of active disease 1.

Diagnosis

  • Serological testing: RPR or VDRL for non-treponemal antibodies, and FTA-ABS or TPHA for treponemal antibodies 1.
  • CSF analysis may be indicated if there is suspicion of neurosyphilis despite negative clinical findings 1.
  • Management

  • No specific treatment required if asymptomatic and serology confirms latent syphilis 1.
  • Initiate treatment with benzathine penicillin G 2.4 million units intramuscularly in a single dose for neurosyphilis prevention if CSF abnormalities are present 1.
  • Special Populations

  • Pregnancy: Asymptomatic late latent syphilis requires careful monitoring and potential treatment initiation to prevent congenital syphilis 1.
  • Elderly: No specific considerations noted in provided abstracts; standard management applies 1.
  • Comorbidities: No specific guidelines provided for managing late latent syphilis in the presence of comorbidities 1.
  • Key Recommendations

  • Monitor asymptomatic patients with late latent syphilis closely without routine treatment unless CSF abnormalities suggest neurosyphilis risk 1 (Evidence: Moderate).
  • Administer benzathine penicillin G 2.4 million units IM for latent syphilis with CSF abnormalities to prevent neurosyphilis 1 (Evidence: Moderate).
  • Pregnant women with late latent syphilis should be closely monitored and treated as necessary to prevent vertical transmission 1 (Evidence: Moderate).
  • References

    1 Modelmog D, Rahlenbeck S, Trichopoulos D. Accuracy of death certificates: a population-based, complete-coverage, one-year autopsy study in East Germany. Cancer causes & control : CCC 1992. link

    Original source

    1. [1]
      Accuracy of death certificates: a population-based, complete-coverage, one-year autopsy study in East Germany.Modelmog D, Rahlenbeck S, Trichopoulos D Cancer causes & control : CCC (1992)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG